Pharmapedia

7 WAYS TO MAINTAIN HEALTH & FITNESS AT MIDDLE-AGE

Getting older involves lots of emotional and physical which can bring a positive or a negative impact on your health. If you want to age gracefully, you need to have a check on your health at the right time. This can only be done by properly understanding and analyzing the changes in your skin, bones, brain and even behaviour and do the needful to maintain your health. You need not only to exercise but to eat, relax and sleep correctly.

Fragrance Ingredients Market to hit US$18.5 billion by 2024

  • Posted on: 5 October 2018
  • By: Shalini.Sharma

The Fragrance Ingredients Market is set to grow from its current market value of more than $11.5 billion to over $18.5 billion by 2024; as reported in the latest study by Global Market Insights, Inc.
Growing penetration rate of international brands, rising demand for personal care products along with growth in cosmetics industry will drive overall fragrance ingredients market demand. These compounds are mixed with personal care products to improve aroma and give freshness to a product. Growing customer spending on beauty products including creams and perfumes supported by growing ageing population may boost industry growth.

EMERGING TRENDS IN ONCOLOGY CLINICAL TRIALS

ABOUT AUTHOR
DR. PRANJAL BORDOLOI
VP – PHARMACOLGY & COD
VEEDA CLINICAL RESEARCH PVT LTD.
info@veedacr.com

Therapeutic innovation in cancer treatment has always been in focus. Based on WHO data, worldwide, there were 14.1 million new cancer cases, 8.2 million cancer deaths, and 32.6 million people living with cancer within 5 years of diagnosis by year 2012. Top 5 most frequent cancers in world (ranked by number of new cases) are breast, prostate, lung, colorectal, and cervical cancers per 2012 WHO data (International Agency for Research on Cancer, WHO). For countries like India, the top 5 most frequent cancers (ranked by number of new cases) are breast, cervical, oral cavity, lung and colorectal cancers (International Agency for Research on Cancer, WHO). Reported age-adjusted incidence rates for cancer are still quite low in the demographically young country. Little more than 1 million new cases of cancer are diagnosed every year in India. An estimated 600 000–700 000 deaths in India were caused by cancer in 2012. In age-standardized terms this is close to the mortality burden seen in high-income countries. Such figures are somewhat indicative of low rates of early-stage detection and poor treatment outcomes (Mallath MK, et al. 2014).

GENERIC VERSUS BRANDED MEDICINES AVAILABLE ON THE LOCAL MARKET

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
Hanan. M. El Bsir1,  Mokhtar. M. El-Baseir2, Abdulrhman  .A . Akasha2*,  Somaia.A . Elsaedi3  and Abdrheam Eluzy2.
1National Medical Research Center,
Zawia, Libya
2Department of Pharmaceutics,
Faculty of Pharmacy, University of Tripoli, Libya
3Minstry of Health,
Tripoli, Libya

ABSTRACT 
This paper presents a survey study of generic and branded medicines available on the local market. The study was carried out on solid dosage forms (Tablets and capsules) for 53 medications available at the time of study in 69 pharmacies located in Tripoli, Libya. Physical specifications (generic name, batch number, manufacture date, expiry date and the manufacturer) as appeared on the package for each product were recorded in a designed form. The retail price at the time of study for each innovator brand and the counterpart generic was also recorded and compared. Results showed that 234 (89%) generics and 29 (11%) branded medicines were available for the studied medicines. The generics medicines were antibiotics (28%), cardiovascular (24.36%), analgesics and antipyretics (12.5%), gastrointestinal (12.8%), for respiratory tract (0.85%), anti-Anthistamin (7.26%), for adiabatic (3%), for vitamins and minerals (6%) and corticosteroid (1%) medicines. The original suppliers of the generics were European countries (42%), Arabian countries (41%) and other region of the world (17%). The retail prices for the generics were significantly (p > 0.05) lower compared to the price of innovator brand counterpart. The study suggests post-marketing surveillance studies for the available generics in comparison to the innovators especially in terms of therapeutic efficiency.

3 FACTS THAT PUSHED AN INDUSTRY FROM ASPIRIN TO ASPIRATION

How technology and innovation will drive the Pharma industry.

Ever since the pyramids were erected in Giza, the need for medication and surgery were required.

During the Stone Age, as early as 3,300 B.C, studies have shown that primitive forms of herbal condiments were used to treat wounds and certain lung disorders. Ayurveda, from the annals of the Hindu Veda scriptures, can be traced back to almost 4,000 B.C. The first institution to train individuals in the field of physiology and medication was established in Italy, around the 15th century.

Why do some microbes live in your gut while others don't?

Trillions of tiny microbes and bacteria live in your gut, each with their own set of genes. These gut microbes can have both beneficial and harmful effects on your health, from protecting you against inflammation to causing life-threatening infections. To keep out pathogens yet encourage the growth of beneficial microbes, scientists have been trying to find ways to target specific microbial genes.

The Needle-free Injection Technology Enjoys Tremendous Opportunity

Injections are a common method of injecting drugs into a patient to prevent or cure diseases. However, it is an invasive mode of drug administration as it causes tissue damage. Moreover, injections can cause the transmission of diseases, especially when needles are repeated or used incorrectly. To get rid of these obstacles, the needle-free injection technology (NFIT) was developed. It has gained enormous popularity in the past few years due to its potential of making the administration of drugs more efficient, safe, less expensive, and convenient.

IN NEXT 25 YEARS PHARMACEUTICAL SCIENCES/MEDICAL SCIENCES PHRASE WILL BE OBSOLETE, AS SMART BODY WILL COME IN AND ARTIFICIAL INTELLIGENCE WILL PLAY CRUCIAL ROLE

ABOUT AUTHOR
Dr. Amit Gangwal
gangwal.amit@gmail.com

A new set of global guidelines on managing diabetes (that plan to replace those followed nearly for thirty years) has been released by American College of Physicians, organization comprising internal medicine physicians. The same has been published in medical journal Annals of Internal Medicine. It says clinicians should aim to achieve an HbA1c level between 7% and 8% in most patients with type 2 diabetes (against the current 6.5 to 7%). This new figure has caused disagreement within the medical community. Medical practitioners in India opine that this may lead to serious complications in diabetics; so it should be ignored for Indians. There were around 72 million diabetics in India in 2017 (as per International Diabetes Federation). HbA1c is long-term blood sugar target, hemoglobin A1C (HbA1c) and it is an estimation of a person’s average blood sugar level over the past few months1.

Speeded-Up Drug Approval Process Will Boost Biologics Market

  • Posted on: 4 July 2018
  • By: PharmaTutor News

The US Federal Drug Administration is aiming to cut the time-to-market and the development costs for new drugs. This will help drive growth in the market for biologics, where over 1000 drugs are currently under development, to 9.6% year on year from its recent rate of 5.4%. Unlike small-molecule drugs that are manufactured through organic or inorganic chemical synthesis, biologics are manufactured by living cells. Biologics are more complex, fragile and difficult to manufacture than small molecules. They cost more to bring to market than the $2 billion average to develop a new drug, despite a trend to outsource development to contract research organizations.

Pages